Merck & Co Inc (NYSE:MRK) has a beta value of 0.42 and has seen 1.34 million shares traded in the recent trading session. The company, currently valued at $255.74B, closed the recent trade at $100.89 per share which meant it lost -$0.98 on the day or -0.96% during that session. The MRK stock price is -33.44% off its 52-week high price of $134.63 and 2.27% above the 52-week low of $98.60. If we look at the company’s 10-day average daily trading volume, we find that it stood at 10.47 million shares traded. The 3-month trading volume is 9.29 million shares.
The consensus among analysts is that Merck & Co Inc (MRK) is Buy stock at the moment, with a recommendation rating of 1.56. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 19 have rated it as a Hold, with 19 advising it as a Buy. 0 have rated the stock as Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Merck & Co Inc (NYSE:MRK) trade information
Sporting -0.96% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the MRK stock price touched $100.89 or saw a rise of 3.91%. Year-to-date, Merck & Co Inc shares have moved -7.46%, while the 5-day performance has seen it change -2.74%. Over the past 30 days, the shares of Merck & Co Inc (NYSE:MRK) have changed -7.09%. Short interest in the company has seen 26.04 million shares shorted with days to cover at 2.71.
Wall Street analysts have a consensus price target for the stock at $132, which means that the shares’ value could jump 23.57% from the levels at last check today.. The projected low price target is $80.0 while the price target rests at a high of $294.0. In that case, then, we find that the latest price level in today’s session is -191.41% off the targeted high while a plunge would see the stock lose 20.71% from the levels at last check today..
Merck & Co Inc (MRK) estimates and forecasts
Figures show that Merck & Co Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -22.62% over the past 6 months, with this year growth rate of 411.92%, compared to 8.20% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -42.70% over the past 5 years. Earnings growth for 2024 is a modest 413.53% while over the next 5 years, the company’s earnings are expected to increase by 23.85%.
MRK Dividends
Merck & Co Inc is expected to release its next earnings report on 2025-Feb-04 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue. The forward dividend is 3.08 at a share yield of 3.05%. The company’s dividend yield has gone up over the past 12 months, with a 5 Year Average Dividend Yield of 2.9%.
Merck & Co Inc (NYSE:MRK)’s Major holders
Insiders own 0.06% of the company shares, while shares held by institutions stand at 79.44% with a share float percentage of 79.49%. Investors are also buoyed by the number of investors in a company, with Merck & Co Inc having a total of 4378.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 244.68 million shares worth more than $30.29 billion. As of 2024-06-30, VANGUARD GROUP INC held 9.6596% of shares outstanding.
The other major institutional holder is BLACKROCK INC., with the holding of over 207.3 million shares as of 2024-06-30. The firm’s total holdings are worth over $25.66 billion and represent 8.1838% of shares outstanding.
